Phillip Gold

Montréal-based BioCapital Investment Advisors, Inc. manages the BioCapital health technology mutual fund family.

BioCurex, Inc. engages in the business of developing, producing, marketing and licensing products based on patented and proprietary technology in the area of cancer diagnostics. It focuses on developing and commercializing products for the early detection, diagnosis, and monitoring the recurrence of cancer. It has developed a blood test that can detect the presence of cancer in humans and animals using a new cancer marker named RECAF. RECAF is a molecule found on most cancer cells, including breast, colon, prostate and lung cancers, but not on normal cells and it also can be used in blood tests to determine if a patient has cancer. The company was founded by Ricardo Moro-Vidal on December 8, 1997 and is headquartered in Richmond, Canada.

Aurelium BioPharma Inc., develops therapeutics and diagnostics for the treatment of drug-resistant cancers. The company has developed several diagnostic tests for the detection of breast, ovarian as well as drug-resistant cancers. The firm has a strong drugable pipeline of novel targets and complimentary diagnostic products that are utilized in its strategic collaborations and out-licensing efforts. The company was founded in May 1998 and is headquartered in Laval, Canada.

Bradmer Pharmaceuticals, Inc. engaged in the development and commercialization of cancer therapies. The company was founded on June 16, 2005 and wass headquartered in Toronto, Canada.

Montréal General Hospital Corp. provides community services. The firm offers patient care through diagnosis, treatment, research, and teaching. The company was founded in 1821 and is headquartered in Montréal, Canada.

Order of Canada is an organization based in Ottawa, Canada. The organization is affiliated with the governor general of Canada, La gouverneure générale du.

WEX Pharmaceuticals, Inc. develops, manufactures, and sells pharmaceutical products for pain management. The pain management solutions are provided through its proprietary platform technology based on TTX (Tetrodotoxin). It owns and operates its research, development and manufacturing facilities in China through its subsidiaries. The company was founded on June 3, 1987 and is headquartered in Vancouver, Canada.

McGill University Health Center provides health care services. The firm offers multidisciplinary patient centric care services. The company was founded in 1997 and is headquartered in Montreal, Canada.